(Total Views: 371)
Posted On: 10/19/2017 1:16:27 PM
Post# of 96896
I agree about the financials.....it will clear up many things people have questions on.
The IR explanation was rule changes from the OTC that screwed things up and required re-submission.
I'm wondering if they are somehow tapping the 21mil by borrowing against it since it''s on the books, like some companies do with their receivables. I don't know if they can do that from a GAAP point of view.
The other explanation would be that they are making enough money to support the operation from company revenue, which would be a big positive if it were true....
The IR explanation was rule changes from the OTC that screwed things up and required re-submission.
I'm wondering if they are somehow tapping the 21mil by borrowing against it since it''s on the books, like some companies do with their receivables. I don't know if they can do that from a GAAP point of view.
The other explanation would be that they are making enough money to support the operation from company revenue, which would be a big positive if it were true....
(0)
(0)
